Form D · Biotechnology

Greyledge Technologies, Inc.

Lone Tree, CO · CIK 0001840347

Offering snapshot reported May 9, 2023 · SEC filing

Reported sold
$4.34M
Offering amount: $4.34M
Investors reported
17
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 11, 2022
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$2.17M$4.34MApr 4, 2022: $1,525,000.00Apr 4, 2022May 20, 2022: $2,700,000.00May 9, 2023: $4,336,052.00May 9, 2023

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,525,000 → $4,336,052
  • Reported investors9 → 17

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 9, 2023Amendment$4,336,052$2,811,052vs Apr 4, 202217SEC filing
May 20, 2022Amendment$2,700,000$1,175,000vs Apr 4, 202217SEC filing
Apr 4, 2022Initial$1,525,000No comparison9SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-440253
Offering is closed.

Source: Form D, filed May 9, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
David Karli Director, Executive
Zoe Bedford Karli Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
10101 Ridgegate Parkway Suite G 01
Lone Tree, CO, 80124